Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia

Saudi Med J. 2004 Dec;25(12):2054-6.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cause of Death
  • Chlorambucil / administration & dosage
  • Chlorambucil / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Retreatment
  • Survival Analysis
  • Turkey
  • Vidarabine / administration & dosage*
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*

Substances

  • Chlorambucil
  • Prednisolone
  • Vidarabine
  • fludarabine